Certified by Founder Lodge
Cytovale
United States - San Francisco, CA
START UP
1 Disclosed Funding Rounds $84,000,000
0 Participating Investments
-
Founded date
2013
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Cytovale is a medical diagnostics company focused on providing a more rapid and insightful way to diagnose fast-moving and immune-mediated diseases. Our FDA cleared IntelliSep test is pioneer
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| November, 16 ,2023 | Series C | $84,000,000 |
Global Health Investment Corporation
Sands Capital
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
HexemBio | $10,400,000 | (Apr 9, 2026)
Trent AI | $13,000,000 | (Apr 9, 2026)
E2 - Endovascular Engineering | $80,000,000 | (Apr 9, 2026)
GoSats - The simplest onramp to Digital Assets in India | $5,000,000 | (Apr 9, 2026)
Aria Networks, Inc. | $125,000,000 | (Apr 9, 2026)
